Abstract 623P
Background
It has been well established that thoracic cancer MDTC is beneficial to patients, healthcare professionals, and to community by providing opportunities for treatments concordant guidelines, educational and professional growth, and reducing inequalities in access to treatment respectively. By identifying the point of view of healthcare professionals, MDTC implementation in thoracic cancers may be improved. We determine the opinions, perceptions, and barriers to an effective MDTC in a Tertiary Hospital in Metro Manila.
Methods
A descriptive study with a total of 57 participants from various healthcare team members involved in the management of thoracic malignancies completed a questionnaire adopted from a previous MDTC survey to identify structure, function, benefits, and barriers perceived.
Results
Of the 20 perceived opinions of healthcare team members, the most common are patient preferences, co-morbidities should always be commented on and develop competence for junior colleagues. A significant proportion of the participants answered that they unaware of monitoring patients for clinical trials. The three predominant benefits identified are multidisciplinary evaluation, complied clinical information and review grants accurate treatment recommendations, and increased patient safety. The three predominant barriers are complex cases, the need for supplementary investigations, and insufficient pathology.
Conclusions
The study was able to identify that the opinion of the healthcare team in MDTCs is centered on the patient’s interests, with emphasis on preferences and comorbidities. Benefits as recognized by the participants include a team-based evaluation to ensure the safety of the patients, with regards to giving the most effective treatment recommendations.
Clinical trial identification
Editorial acknowledgement
While preparing this work, the authors used the GRAMMARLY DESKTOP APP to enhance the grammar correctness and improvement of statements. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.